Marcia Wilson

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models

J. Dowty, C. Apicella, N. Lindor, 2007, Familial Cancer.

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999

N. Lindor, B. Morlan, T. Fallen, 2005, Familial Cancer.

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

Susan M. Domchek, Fergus Couch, Kiley J. Johnson, 2010, Familial Cancer.

Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.

A. Weaver, M. Greene, N. Lindor, 2001, Genetic testing.